hit counter

Stress Social Deficits Reversed by Amygdala-Oxytocin Circuit Suppression

MHD featured image for stress-induced social changes, mPFC, amygdala, and oxytocin circuits.

A 2026 mouse circuit study found that restraint stress progressively reduced medial prefrontal social coding: mPFC excitatory-neuron transient rates fell to roughly 70-80% of baseline after acute stress and nearly 50% after chronic stress, while suppressing either basolateral-amygdala input or hypothalamic oxytocin input restored social discrimination and behavior.1 The result is a circuit-specific oxytocin finding, …

Read more

Latest Treatments for Frontotemporal Dementia (FTD): High-Dose Oxytocin Emerges as the Standout (2023 Review)

Frontotemporal dementia (FTD) is a challenging and impactful neurodegenerative disease. Recent research offers new insights into its management, particularly regarding the effectiveness of pharmacological treatments. Highlights: High-Dose Oxytocin Shows Promise: High-dose oxytocin (72 international units) has been linked to significant improvements in neuropsychiatric symptoms and daily interactive activities in FTD patients. Piracetam Poses Risks: Contrarily, …

Read more

Buspar (Buspirone) For Depression: Exploring The Antidepressant Potential

Buspar (Buspirone) is a drug of the azapirone chemical classification that was engineered and patented in the 1970s by Mead Johnson.  It was later acquired by the pharmaceutical company Bristol-Myers Squibb and approved by the FDA in 1986 for the treatment of generalized anxiety disorder (GAD).  What’s unique about buspirone compared to other anxiolytics such …

Read more